Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer.
Kantoff
P W
PW
Dana-Farber Cancer Institute, Harvard Medical School, Boston.
Garnick
M B
MB
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*